Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
C R NicholsP J Loehrer

Abstract

To compare standard therapy with bleomycin, etoposide, and cisplatin (BEP) to experimental therapy with etoposide, ifosfamide, and cisplatin (VIP) as primary treatment of men with advanced, disseminated germ cell tumors. A total of 304 men with advanced disseminated germ cell tumors were randomly allocated to receive four courses of BEP or VIP. Two hundred ninety-nine patients were assessable for toxicity and 286 were assessable for response. Complete response rates, favorable response (complete remission, surgical free of disease, continuous partial remission for 2+ years), time to treatment failure, and overall survival were assessed. Overall complete remission rate (VIP, 37%; BEP, 31%), favorable response rate (VIP, 63%; BEP, 60%), failure-free at 2 years (VIP, 64%; BEP, 60%), and 2-year overall survival (VIP, 74%; BEP, 71%) were not significantly different between the two treatments. Grade 3 or worse toxicity, particularly hematologic and genitourinary toxicity, was significantly more common in patients who received VIP. BEP and VIP produce comparable favorable response rate and survival in patients with poor-risk germ cell tumors. The substitution of ifosfamide for bleomycin, however, was associated with significantly grea...Continue Reading

Citations

May 18, 1999·Current Opinion in Oncology·R T Oliver
Dec 10, 1999·Seminars in Surgical Oncology·G J Bosl
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·R de WitJ Schornagel
Jan 22, 2002·American Journal of Clinical Oncology·E W WinquistJ Balogh
Oct 31, 2003·Expert Opinion on Drug Safety·Koji Kawai, Hideyuki Akaza
Aug 27, 2004·BJU International·Ellen CopsonGraham Z Mead
Sep 18, 2007·Der Urologe. Ausg. A·S Langenkamp, P Albers
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph R CarverUNKNOWN ASCO Cancer Survivorship Expert Panel
Jun 15, 2010·International Journal of Clinical Oncology·Shuya KandoriHideyuki Akaza
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vamshi KavetiSushma Ganeshula
Jun 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy D GilliganUNKNOWN American Society of Clinical Oncology
Oct 9, 2013·Japanese Journal of Clinical Oncology·Hiromu InaiHiroyuki Nishiyama
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio GandagliaMaxine Sun
Apr 10, 2014·British Journal of Haematology·George A FollowsUNKNOWN British Committee for Standards in Haematology
Feb 12, 2017·Oncotarget·Vlad C SandulacheStephen Y Lai
Apr 25, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ali McBrideKurt Weibel
Aug 11, 2020·Journal of Cancer Research and Clinical Oncology·Marcus HentrichArthur Gerl
Mar 21, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Y KubotaT Nakada
Apr 8, 2004·Current Opinion in Oncology·Gary R MacVicar, Kenneth J Pienta
Apr 26, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu Miki, Masahiro Nakao
Dec 14, 2004·Der Urologe. Ausg. A·J Beyer, C Bokemeyer
May 22, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P PautierC Lhommé
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
Feb 20, 2009·International Journal of Clinical Oncology·Hector MesaPankaj Gupta
Mar 31, 2009·World Journal of Urology·Matthew J Riese, David J Vaughn
Apr 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Esther C de HaasJourik A Gietema
Mar 16, 2011·Nature Reviews. Urology·Chunkit Fung, David J Vaughn
Jun 1, 2014·Journal of Drug Targeting·Mostafa ShahinAfsaneh Lavasanifar
Aug 9, 2011·Radiation Oncology·Noureddine BoujelbeneAbderrahim Zouhair
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
Dec 25, 2013·Annals of the American Thoracic Society·Grace Y LinJinghong Li
Aug 5, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chunkit FungLois B Travis
Sep 23, 2014·Expert Opinion on Biological Therapy·Andrea NecchiUNKNOWN European Society for Blood and Marrow Transplantation, Solid Tumors Working Party (EBMT-STWP) and the Italian Germ Cell Canc
Jul 7, 2018·Current Opinion in Urology·Costantine Albany
Oct 7, 2018·Nature Reviews. Disease Primers·Liang ChengLeendert H J Looijenga
Mar 9, 2019·Expert Opinion on Pharmacotherapy·Winfried AlsdorfChristoph Oing
Jun 1, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S Culine, J P Droz
Mar 11, 2005·Expert Review of Anticancer Therapy·Robert A Huddart, Alison J Birtle
Dec 1, 1999·Current Opinion in Urology·H J Schmoll
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·M J Morris, G J Bosl
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Varuni Kondagunta, Robert J Motzer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.